Lactosylated Gramicidin-Based Lipid Nanoparticles (Lac-Gln) for Targeted Delivery of Anti-miR-155 to Hepatocellular Carcinoma
Journal of Controlled Release - Netherlands
doi 10.1016/j.jconrel.2013.03.020
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2013
Authors
Publisher
Elsevier BV